Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FAVBU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,986
Award facts
- Contract value 100% obligated
- $34,986.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency (DLA) on April 21, 2025, for Kesimpta 20 mg/0.4 mL pen injections valued at $34,986.15. This firm fixed-price delivery order, which is scheduled for completion by April 22, 2025, will be performed in Conshohocken, Pennsylvania. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement marketplace based on its qualifications as a small business pharmaceutical supplier.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. Kesimpta is a specialty pharmaceutical product used in federal healthcare settings, and this award exemplifies DMS Pharmaceutical Group's role as a critical supplier in the Department of Defense pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to military healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FAVBU?
SPE2DB25FAVBU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FAVBU worth?
The government has obligated $34,986 on SPE2DB25FAVBU.
Is contract SPE2DB25FAVBU an order under another contract?
Yes. SPE2DB25FAVBU is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVBU competed?
The extent of competition for SPE2DB25FAVBU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award